| scholarly article | Q13442814 |
| P2093 | author name string | Chave JP | |
| Blaser J | |||
| Joos B | |||
| Lüthy R | |||
| Opravil M | |||
| P2860 | cites work | Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS | Q28268439 |
| Adverse reactions to co-trimoxazole in HIV infection | Q36509421 | ||
| Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients | Q39778838 | ||
| Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men | Q40832328 | ||
| Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia | Q40913176 | ||
| Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study | Q42212013 | ||
| Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. | Q44512773 | ||
| Serum trimethoprim and sulphamethoxazole levels in AIDS. | Q44577634 | ||
| Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients | Q45785601 | ||
| Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. | Q50764274 | ||
| Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. | Q50897805 | ||
| Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions | Q68183652 | ||
| Sulphamethoxazole acetylation in fast and slow acetylators | Q68781722 | ||
| Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial | Q68882155 | ||
| Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites | Q69941103 | ||
| Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients | Q72061237 | ||
| Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? | Q72250696 | ||
| Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy | Q72568623 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| sulfamethoxazole/trimethoprim | Q898623 | ||
| Pneumocystis carinii | Q2099992 | ||
| P304 | page(s) | 2661-2666 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia | |
| P478 | volume | 39 |
| Q28138550 | A common polymorphism associated with antibiotic-induced cardiac arrhythmia |
| Q57302816 | Antiprotozoal drugs |
| Q45070975 | Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients. |
| Q37634515 | Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients |
| Q34109528 | In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species |
| Q44620842 | N ‐glycosylation‐dependent block is a novel mechanism for drug‐induced cardiac arrhythmia |
| Q41692938 | Pneumonia in AIDS patients in the critical care unit |
| Q47689257 | Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. |
| Q21133667 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review |
| Q34498991 | Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study |
| Q46137577 | Straightforward and rapid determination of sulfadoxine and sulfamethoxazole in capillary blood on sampling paper with liquid chromatography and UV detection |
| Q40097078 | Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines |
| Q27684698 | Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs |
| Q40092648 | Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. |
| Q24519016 | Treatment of infection due to Pneumocystis carinii |
| Q37782191 | Update on the diagnosis and treatment ofPneumocystispneumonia |
Search more.